278 related articles for article (PubMed ID: 17336288)
1. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
2. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.
Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Arias-Carrión O; Drucker-Colín R
PLoS One; 2011; 6(7):e20766. PubMed ID: 21779318
[TBL] [Abstract][Full Text] [Related]
3. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats.
Murillo-Rodríguez E; Millán-Aldaco D; Palomero-Rivero M; Mechoulam R; Drucker-Colín R
FEBS Lett; 2006 Aug; 580(18):4337-45. PubMed ID: 16844117
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
6. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis.
Murillo-Rodríguez E; Machado S; Rocha NB; Budde H; Yuan TF; Arias-Carrión O
Neuroscience; 2016 Dec; 339():433-449. PubMed ID: 27746343
[TBL] [Abstract][Full Text] [Related]
7. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
[TBL] [Abstract][Full Text] [Related]
8. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
[TBL] [Abstract][Full Text] [Related]
9. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats.
Solinas M; Justinova Z; Goldberg SR; Tanda G
J Neurochem; 2006 Jul; 98(2):408-19. PubMed ID: 16805835
[TBL] [Abstract][Full Text] [Related]
10. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
Bosier B; Muccioli GG; Lambert DM
Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure.
Rivera P; Fernández-Arjona MDM; Silva-Peña D; Blanco E; Vargas A; López-Ávalos MD; Grondona JM; Serrano A; Pavón FJ; Rodríguez de Fonseca F; Suárez J
Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312
[TBL] [Abstract][Full Text] [Related]
13. Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors.
Luchicchi A; Lecca S; Carta S; Pillolla G; Muntoni AL; Yasar S; Goldberg SR; Pistis M
Addict Biol; 2010 Jul; 15(3):277-88. PubMed ID: 20477753
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
Scherma M; Panlilio LV; Fadda P; Fattore L; Gamaleddin I; Le Foll B; Justinová Z; Mikics E; Haller J; Medalie J; Stroik J; Barnes C; Yasar S; Tanda G; Piomelli D; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease.
Johnston TH; Huot P; Fox SH; Wakefield JD; Sykes KA; Bartolini WP; Milne GT; Pearson JP; Brotchie JM
J Pharmacol Exp Ther; 2011 Feb; 336(2):423-30. PubMed ID: 20966038
[TBL] [Abstract][Full Text] [Related]
16. Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation.
Soria-Gómez E; Guzmán K; Pech-Rueda O; Montes-Rodríguez CJ; Cisneros M; Prospéro-García O
Pharmacol Res; 2010 May; 61(5):379-84. PubMed ID: 20100574
[TBL] [Abstract][Full Text] [Related]
17. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
18. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
Jhaveri MD; Richardson D; Kendall DA; Barrett DA; Chapman V
J Neurosci; 2006 Dec; 26(51):13318-27. PubMed ID: 17182782
[TBL] [Abstract][Full Text] [Related]
19. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR
Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
